NCT03882021 - High-Density (HD) Wave Mapping in Subjects With Atrial Fibrillation as a Predictor of Recurrence After a Single Ablation Procedure Using a PVI-Only Strategy | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

August 26, 2019

Primary Completion Date

November 30, 2021

Study Completion Date

January 13, 2022

Conditions

Paroxysmal Atrial FibrillationPersistent Atrial FibrillationCardiac Arrhythmia

Interventions

PROCEDURE

A specific electrophysiology mapping protocol is applicable with the GRID catheter.

The procedure will be done according to a standard ablation approach. During the electrophysiology study, additional mapping data will be collected to support the study endpoints using the GRID catheter.

Trial Locations (15)

4021

Kepler Universitätsklinikum GmbH, Linz

15706

Complexo Hospitalario Universitario de Santiago, Santiago de Compostela

20132

Ospedale San Raffaele, Milan

29549

Herz- u. Gefäßzentrum Bad Bevensen, Bad Bevensen

32545

Herz- und Diabeteszentrum NRW, Bad Oeynhausen

44200

Hôpital Privé du Confluent, Nantes

56126

Azienda Ospedaliero Universitaria Pisana, Pisa

69626

Médipôle Lyon-Villeurbanne, Villeurbanne

85049

Klinikum Ingolstadt GmbH, Ingolstadt

97405

CHR de La Reunion - Site du CHFG, Saint-Denis

656 91

FN U sv. Anny v Brno, Brno

9713 GZ

Universitair Medische Centrum Groningen, Groningen

2799-523

Hospital de Santa Cruz, Carnaxide

08035

Hospital Universitario Vall d'Hebron, Barcelona

OX3 9DU

John Radcliffe Hospital, Oxford